nodes	percent_of_prediction	percent_of_DWPC	metapath
Diflunisal—PTGS2—Etoposide—brain cancer	0.151	0.542	CbGbCtD
Diflunisal—PTGS1—Etoposide—brain cancer	0.127	0.458	CbGbCtD
Diflunisal—TTR—choroid plexus—brain cancer	0.1	0.361	CbGeAlD
Diflunisal—TTR—pineal body—brain cancer	0.0254	0.0918	CbGeAlD
Diflunisal—Niclosamide—STAT3—brain cancer	0.0187	0.619	CrCbGaD
Diflunisal—TTR—hindbrain—brain cancer	0.0138	0.0499	CbGeAlD
Diflunisal—UGT1A8—endocrine gland—brain cancer	0.00967	0.0349	CbGeAlD
Diflunisal—UGT1A8—head—brain cancer	0.00955	0.0344	CbGeAlD
Diflunisal—Disorientation—Lomustine—brain cancer	0.00854	0.0223	CcSEcCtD
Diflunisal—Visual disturbance—Lomustine—brain cancer	0.00806	0.021	CcSEcCtD
Diflunisal—TTR—brainstem—brain cancer	0.00793	0.0286	CbGeAlD
Diflunisal—TTR—telencephalon—brain cancer	0.00704	0.0254	CbGeAlD
Diflunisal—Hearing impaired—Procarbazine—brain cancer	0.00702	0.0183	CcSEcCtD
Diflunisal—Niclosamide—CYP2C9—brain cancer	0.00682	0.225	CrCbGaD
Diflunisal—UGT1A8—Tamoxifen metabolism—CYP2C9—brain cancer	0.00669	0.212	CbGpPWpGaD
Diflunisal—PTGS1—ganglion—brain cancer	0.00664	0.024	CbGeAlD
Diflunisal—Renal failure—Lomustine—brain cancer	0.00579	0.0151	CcSEcCtD
Diflunisal—Stomatitis—Lomustine—brain cancer	0.00574	0.015	CcSEcCtD
Diflunisal—TTR—pituitary gland—brain cancer	0.00573	0.0207	CbGeAlD
Diflunisal—PTGS1—endothelium—brain cancer	0.00572	0.0207	CbGeAlD
Diflunisal—TTR—medulla oblongata—brain cancer	0.00553	0.02	CbGeAlD
Diflunisal—Photosensitivity—Procarbazine—brain cancer	0.00552	0.0144	CcSEcCtD
Diflunisal—PTGS2—endothelium—brain cancer	0.00547	0.0197	CbGeAlD
Diflunisal—Disorientation—Procarbazine—brain cancer	0.00542	0.0141	CcSEcCtD
Diflunisal—Deafness—Procarbazine—brain cancer	0.00542	0.0141	CcSEcCtD
Diflunisal—Haemolytic anaemia—Procarbazine—brain cancer	0.00537	0.014	CcSEcCtD
Diflunisal—Cholestasis—Temozolomide—brain cancer	0.00532	0.0139	CcSEcCtD
Diflunisal—PTGS1—blood vessel—brain cancer	0.00528	0.019	CbGeAlD
Diflunisal—Visual impairment—Lomustine—brain cancer	0.00509	0.0133	CcSEcCtD
Diflunisal—TTR—midbrain—brain cancer	0.00506	0.0182	CbGeAlD
Diflunisal—PTGS2—blood vessel—brain cancer	0.00505	0.0182	CbGeAlD
Diflunisal—TTR—spinal cord—brain cancer	0.00493	0.0178	CbGeAlD
Diflunisal—TTR—endocrine gland—brain cancer	0.00444	0.016	CbGeAlD
Diflunisal—TTR—head—brain cancer	0.00438	0.0158	CbGeAlD
Diflunisal—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.00437	0.0114	CcSEcCtD
Diflunisal—Hearing impaired—Temozolomide—brain cancer	0.00424	0.0111	CcSEcCtD
Diflunisal—Disorientation—Hydroxyurea—brain cancer	0.0042	0.0109	CcSEcCtD
Diflunisal—TTR—central nervous system—brain cancer	0.004	0.0144	CbGeAlD
Diflunisal—TTR—cerebellum—brain cancer	0.00391	0.0141	CbGeAlD
Diflunisal—Photosensitivity reaction—Procarbazine—brain cancer	0.00383	0.00998	CcSEcCtD
Diflunisal—Thrombocytopenia—Lomustine—brain cancer	0.00368	0.00959	CcSEcCtD
Diflunisal—Stomatitis—Procarbazine—brain cancer	0.00364	0.00951	CcSEcCtD
Diflunisal—Jaundice—Procarbazine—brain cancer	0.00364	0.00951	CcSEcCtD
Diflunisal—Sweating—Procarbazine—brain cancer	0.00358	0.00935	CcSEcCtD
Diflunisal—Anorexia—Lomustine—brain cancer	0.00358	0.00934	CcSEcCtD
Diflunisal—Haematuria—Procarbazine—brain cancer	0.00356	0.0093	CcSEcCtD
Diflunisal—Body temperature increased—Carboplatin—brain cancer	0.00339	0.00885	CcSEcCtD
Diflunisal—Hallucination—Procarbazine—brain cancer	0.00334	0.00871	CcSEcCtD
Diflunisal—Deafness—Temozolomide—brain cancer	0.00328	0.00855	CcSEcCtD
Diflunisal—Decreased appetite—Lomustine—brain cancer	0.00326	0.00852	CcSEcCtD
Diflunisal—SLC22A6—brain—brain cancer	0.00325	0.0117	CbGeAlD
Diflunisal—TTR—brain—brain cancer	0.00318	0.0115	CbGeAlD
Diflunisal—Flushing—Procarbazine—brain cancer	0.00311	0.00812	CcSEcCtD
Diflunisal—Dermatitis exfoliative—Temozolomide—brain cancer	0.00311	0.00811	CcSEcCtD
Diflunisal—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.00303	0.00792	CcSEcCtD
Diflunisal—Dysuria—Hydroxyurea—brain cancer	0.00303	0.00792	CcSEcCtD
Diflunisal—Body temperature increased—Lomustine—brain cancer	0.00297	0.00774	CcSEcCtD
Diflunisal—Tension—Procarbazine—brain cancer	0.00287	0.00748	CcSEcCtD
Diflunisal—Nervousness—Procarbazine—brain cancer	0.00284	0.0074	CcSEcCtD
Diflunisal—Stomatitis—Hydroxyurea—brain cancer	0.00282	0.00736	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.00264	0.00689	CcSEcCtD
Diflunisal—Syncope—Procarbazine—brain cancer	0.00262	0.00683	CcSEcCtD
Diflunisal—Hallucination—Hydroxyurea—brain cancer	0.00258	0.00674	CcSEcCtD
Diflunisal—Loss of consciousness—Procarbazine—brain cancer	0.00257	0.0067	CcSEcCtD
Diflunisal—PTGS1—telencephalon—brain cancer	0.00256	0.00924	CbGeAlD
Diflunisal—Salicylic acid—CYP2C9—brain cancer	0.00251	0.0831	CrCbGaD
Diflunisal—PTGS2—telencephalon—brain cancer	0.00245	0.00883	CbGeAlD
Diflunisal—Confusional state—Procarbazine—brain cancer	0.0024	0.00627	CcSEcCtD
Diflunisal—Vomiting—Lomustine—brain cancer	0.00239	0.00623	CcSEcCtD
Diflunisal—Oedema—Procarbazine—brain cancer	0.00238	0.00622	CcSEcCtD
Diflunisal—Dysuria—Temozolomide—brain cancer	0.00237	0.00618	CcSEcCtD
Diflunisal—Shock—Procarbazine—brain cancer	0.00235	0.00612	CcSEcCtD
Diflunisal—Thrombocytopenia—Procarbazine—brain cancer	0.00233	0.00609	CcSEcCtD
Diflunisal—Photosensitivity reaction—Temozolomide—brain cancer	0.00231	0.00604	CcSEcCtD
Diflunisal—PTGS1—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00231	0.073	CbGpPWpGaD
Diflunisal—Hyperhidrosis—Procarbazine—brain cancer	0.0023	0.00601	CcSEcCtD
Diflunisal—Renal failure—Carmustine—brain cancer	0.0023	0.006	CcSEcCtD
Diflunisal—Stomatitis—Carmustine—brain cancer	0.00228	0.00595	CcSEcCtD
Diflunisal—Anorexia—Procarbazine—brain cancer	0.00227	0.00593	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00224	0.00585	CcSEcCtD
Diflunisal—Nausea—Lomustine—brain cancer	0.00223	0.00582	CcSEcCtD
Diflunisal—Flurbiprofen—CYP2C9—brain cancer	0.0022	0.0728	CrCbGaD
Diflunisal—Stomatitis—Temozolomide—brain cancer	0.0022	0.00575	CcSEcCtD
Diflunisal—Insomnia—Procarbazine—brain cancer	0.00216	0.00563	CcSEcCtD
Diflunisal—Paraesthesia—Procarbazine—brain cancer	0.00214	0.00558	CcSEcCtD
Diflunisal—Somnolence—Procarbazine—brain cancer	0.00212	0.00553	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Etoposide—brain cancer	0.00211	0.00551	CcSEcCtD
Diflunisal—Cramp muscle—Etoposide—brain cancer	0.00211	0.00551	CcSEcCtD
Diflunisal—Hallucination—Carmustine—brain cancer	0.00209	0.00545	CcSEcCtD
Diflunisal—PTGS1—pituitary gland—brain cancer	0.00209	0.00752	CbGeAlD
Diflunisal—Decreased appetite—Procarbazine—brain cancer	0.00207	0.00541	CcSEcCtD
Diflunisal—Fatigue—Procarbazine—brain cancer	0.00206	0.00536	CcSEcCtD
Diflunisal—Constipation—Procarbazine—brain cancer	0.00204	0.00532	CcSEcCtD
Diflunisal—Hepatitis—Temozolomide—brain cancer	0.00203	0.00529	CcSEcCtD
Diflunisal—ALB—brain—brain cancer	0.00203	0.00732	CbGeAlD
Diflunisal—Visual impairment—Carmustine—brain cancer	0.00202	0.00528	CcSEcCtD
Diflunisal—Hallucination—Temozolomide—brain cancer	0.00202	0.00527	CcSEcCtD
Diflunisal—Bronchospasm—Etoposide—brain cancer	0.00199	0.0052	CcSEcCtD
Diflunisal—PTGS2—pituitary gland—brain cancer	0.00199	0.00719	CbGeAlD
Diflunisal—Feeling abnormal—Procarbazine—brain cancer	0.00196	0.00513	CcSEcCtD
Diflunisal—Visual impairment—Temozolomide—brain cancer	0.00196	0.0051	CcSEcCtD
Diflunisal—Gastrointestinal pain—Procarbazine—brain cancer	0.00195	0.00509	CcSEcCtD
Diflunisal—Flushing—Carmustine—brain cancer	0.00195	0.00508	CcSEcCtD
Diflunisal—PTGS2—medulla oblongata—brain cancer	0.00192	0.00694	CbGeAlD
Diflunisal—Erythema multiforme—Temozolomide—brain cancer	0.00192	0.005	CcSEcCtD
Diflunisal—Urticaria—Procarbazine—brain cancer	0.00189	0.00494	CcSEcCtD
Diflunisal—Tinnitus—Temozolomide—brain cancer	0.00189	0.00493	CcSEcCtD
Diflunisal—Body temperature increased—Procarbazine—brain cancer	0.00188	0.00492	CcSEcCtD
Diflunisal—Flushing—Temozolomide—brain cancer	0.00188	0.00491	CcSEcCtD
Diflunisal—Oedema—Hydroxyurea—brain cancer	0.00184	0.00481	CcSEcCtD
Diflunisal—PTGS2—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00183	0.058	CbGpPWpGaD
Diflunisal—Thrombocytopenia—Hydroxyurea—brain cancer	0.00181	0.00471	CcSEcCtD
Diflunisal—PTGS1—spinal cord—brain cancer	0.00179	0.00647	CbGeAlD
Diflunisal—Stevens-Johnson syndrome—Etoposide—brain cancer	0.00179	0.00468	CcSEcCtD
Diflunisal—Renal failure—Etoposide—brain cancer	0.00178	0.00464	CcSEcCtD
Diflunisal—Stomatitis—Etoposide—brain cancer	0.00176	0.0046	CcSEcCtD
Diflunisal—Jaundice—Etoposide—brain cancer	0.00176	0.0046	CcSEcCtD
Diflunisal—Anorexia—Hydroxyurea—brain cancer	0.00176	0.00459	CcSEcCtD
Diflunisal—PTGS2—midbrain—brain cancer	0.00176	0.00634	CbGeAlD
Diflunisal—Hypersensitivity—Procarbazine—brain cancer	0.00176	0.00458	CcSEcCtD
Diflunisal—Vision blurred—Carmustine—brain cancer	0.00172	0.00449	CcSEcCtD
Diflunisal—PTGS2—spinal cord—brain cancer	0.00172	0.00619	CbGeAlD
Diflunisal—Asthenia—Procarbazine—brain cancer	0.00171	0.00446	CcSEcCtD
Diflunisal—Agranulocytosis—Etoposide—brain cancer	0.00169	0.0044	CcSEcCtD
Diflunisal—Pruritus—Procarbazine—brain cancer	0.00169	0.0044	CcSEcCtD
Diflunisal—Vision blurred—Temozolomide—brain cancer	0.00166	0.00434	CcSEcCtD
Diflunisal—Dyspnoea—Hydroxyurea—brain cancer	0.00164	0.00429	CcSEcCtD
Diflunisal—Somnolence—Hydroxyurea—brain cancer	0.00164	0.00428	CcSEcCtD
Diflunisal—Diarrhoea—Procarbazine—brain cancer	0.00163	0.00426	CcSEcCtD
Diflunisal—Dyspepsia—Hydroxyurea—brain cancer	0.00162	0.00424	CcSEcCtD
Diflunisal—PTGS1—endocrine gland—brain cancer	0.00162	0.00583	CbGeAlD
Diflunisal—Angioedema—Temozolomide—brain cancer	0.00161	0.00421	CcSEcCtD
Diflunisal—Decreased appetite—Hydroxyurea—brain cancer	0.0016	0.00418	CcSEcCtD
Diflunisal—PTGS1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.0016	0.0506	CbGpPWpGaD
Diflunisal—PTGS1—head—brain cancer	0.00159	0.00575	CbGeAlD
Diflunisal—Fatigue—Hydroxyurea—brain cancer	0.00159	0.00415	CcSEcCtD
Diflunisal—Vertigo—Temozolomide—brain cancer	0.00159	0.00414	CcSEcCtD
Diflunisal—Constipation—Hydroxyurea—brain cancer	0.00158	0.00412	CcSEcCtD
Diflunisal—Dizziness—Procarbazine—brain cancer	0.00158	0.00411	CcSEcCtD
Diflunisal—Palpitations—Temozolomide—brain cancer	0.00156	0.00407	CcSEcCtD
Diflunisal—Chest pain—Carmustine—brain cancer	0.00156	0.00406	CcSEcCtD
Diflunisal—PTGS2—endocrine gland—brain cancer	0.00154	0.00557	CbGeAlD
Diflunisal—Erythema multiforme—Etoposide—brain cancer	0.00153	0.004	CcSEcCtD
Diflunisal—PTGS2—head—brain cancer	0.00152	0.0055	CbGeAlD
Diflunisal—Feeling abnormal—Hydroxyurea—brain cancer	0.00152	0.00397	CcSEcCtD
Diflunisal—Vomiting—Procarbazine—brain cancer	0.00152	0.00395	CcSEcCtD
Diflunisal—Flushing—Etoposide—brain cancer	0.00151	0.00393	CcSEcCtD
Diflunisal—Confusional state—Carmustine—brain cancer	0.0015	0.00392	CcSEcCtD
Diflunisal—Rash—Procarbazine—brain cancer	0.0015	0.00392	CcSEcCtD
Diflunisal—Dermatitis—Procarbazine—brain cancer	0.0015	0.00392	CcSEcCtD
Diflunisal—Headache—Procarbazine—brain cancer	0.00149	0.0039	CcSEcCtD
Diflunisal—Oedema—Carmustine—brain cancer	0.00149	0.00389	CcSEcCtD
Diflunisal—Thrombocytopenia—Carmustine—brain cancer	0.00146	0.00381	CcSEcCtD
Diflunisal—Body temperature increased—Hydroxyurea—brain cancer	0.00146	0.00381	CcSEcCtD
Diflunisal—PTGS1—central nervous system—brain cancer	0.00146	0.00525	CbGeAlD
Diflunisal—Confusional state—Temozolomide—brain cancer	0.00145	0.00379	CcSEcCtD
Diflunisal—Anaphylactic shock—Temozolomide—brain cancer	0.00144	0.00376	CcSEcCtD
Diflunisal—Oedema—Temozolomide—brain cancer	0.00144	0.00376	CcSEcCtD
Diflunisal—Anorexia—Carmustine—brain cancer	0.00142	0.00371	CcSEcCtD
Diflunisal—Nausea—Procarbazine—brain cancer	0.00142	0.00369	CcSEcCtD
Diflunisal—Thrombocytopenia—Temozolomide—brain cancer	0.00141	0.00368	CcSEcCtD
Diflunisal—Hyperhidrosis—Temozolomide—brain cancer	0.00139	0.00364	CcSEcCtD
Diflunisal—PTGS2—central nervous system—brain cancer	0.00139	0.00502	CbGeAlD
Diflunisal—Anorexia—Temozolomide—brain cancer	0.00137	0.00358	CcSEcCtD
Diflunisal—PTGS2—cerebellum—brain cancer	0.00136	0.00491	CbGeAlD
Diflunisal—Hypersensitivity—Hydroxyurea—brain cancer	0.00136	0.00355	CcSEcCtD
Diflunisal—Muscle spasms—Etoposide—brain cancer	0.00136	0.00354	CcSEcCtD
Diflunisal—Insomnia—Carmustine—brain cancer	0.00135	0.00352	CcSEcCtD
Diflunisal—Paraesthesia—Carmustine—brain cancer	0.00134	0.00349	CcSEcCtD
Diflunisal—Dyspnoea—Carmustine—brain cancer	0.00133	0.00347	CcSEcCtD
Diflunisal—Somnolence—Carmustine—brain cancer	0.00133	0.00346	CcSEcCtD
Diflunisal—Asthenia—Hydroxyurea—brain cancer	0.00132	0.00345	CcSEcCtD
Diflunisal—Insomnia—Temozolomide—brain cancer	0.0013	0.0034	CcSEcCtD
Diflunisal—Decreased appetite—Carmustine—brain cancer	0.0013	0.00338	CcSEcCtD
Diflunisal—Paraesthesia—Temozolomide—brain cancer	0.00129	0.00338	CcSEcCtD
Diflunisal—Dyspnoea—Temozolomide—brain cancer	0.00128	0.00335	CcSEcCtD
Diflunisal—Somnolence—Temozolomide—brain cancer	0.00128	0.00334	CcSEcCtD
Diflunisal—Constipation—Carmustine—brain cancer	0.00128	0.00333	CcSEcCtD
Diflunisal—PTGS2—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.00127	0.0402	CbGpPWpGaD
Diflunisal—Vertigo—Etoposide—brain cancer	0.00127	0.00331	CcSEcCtD
Diflunisal—Dyspepsia—Temozolomide—brain cancer	0.00127	0.00331	CcSEcCtD
Diflunisal—Diarrhoea—Hydroxyurea—brain cancer	0.00126	0.00329	CcSEcCtD
Diflunisal—Decreased appetite—Temozolomide—brain cancer	0.00125	0.00327	CcSEcCtD
Diflunisal—UGT1A8—Biological oxidations—CYP2C9—brain cancer	0.00124	0.0393	CbGpPWpGaD
Diflunisal—Fatigue—Temozolomide—brain cancer	0.00124	0.00324	CcSEcCtD
Diflunisal—Loss of consciousness—Etoposide—brain cancer	0.00124	0.00324	CcSEcCtD
Diflunisal—Constipation—Temozolomide—brain cancer	0.00123	0.00322	CcSEcCtD
Diflunisal—Feeling abnormal—Carmustine—brain cancer	0.00123	0.00321	CcSEcCtD
Diflunisal—Dizziness—Hydroxyurea—brain cancer	0.00122	0.00318	CcSEcCtD
Diflunisal—Gastrointestinal pain—Carmustine—brain cancer	0.00122	0.00318	CcSEcCtD
Diflunisal—Chest pain—Etoposide—brain cancer	0.0012	0.00314	CcSEcCtD
Diflunisal—Feeling abnormal—Temozolomide—brain cancer	0.00119	0.0031	CcSEcCtD
Diflunisal—Body temperature increased—Carmustine—brain cancer	0.00118	0.00308	CcSEcCtD
Diflunisal—Gastrointestinal pain—Temozolomide—brain cancer	0.00118	0.00307	CcSEcCtD
Diflunisal—Vomiting—Hydroxyurea—brain cancer	0.00117	0.00306	CcSEcCtD
Diflunisal—Rash—Hydroxyurea—brain cancer	0.00116	0.00304	CcSEcCtD
Diflunisal—Confusional state—Etoposide—brain cancer	0.00116	0.00303	CcSEcCtD
Diflunisal—Dermatitis—Hydroxyurea—brain cancer	0.00116	0.00303	CcSEcCtD
Diflunisal—Headache—Hydroxyurea—brain cancer	0.00116	0.00302	CcSEcCtD
Diflunisal—PTGS1—brain—brain cancer	0.00116	0.00417	CbGeAlD
Diflunisal—Anaphylactic shock—Etoposide—brain cancer	0.00115	0.00301	CcSEcCtD
Diflunisal—Urticaria—Temozolomide—brain cancer	0.00114	0.00299	CcSEcCtD
Diflunisal—Body temperature increased—Temozolomide—brain cancer	0.00114	0.00297	CcSEcCtD
Diflunisal—Thrombocytopenia—Etoposide—brain cancer	0.00113	0.00295	CcSEcCtD
Diflunisal—Hyperhidrosis—Etoposide—brain cancer	0.00111	0.00291	CcSEcCtD
Diflunisal—PTGS2—brain—brain cancer	0.0011	0.00398	CbGeAlD
Diflunisal—Anorexia—Etoposide—brain cancer	0.0011	0.00287	CcSEcCtD
Diflunisal—Hypersensitivity—Carmustine—brain cancer	0.0011	0.00287	CcSEcCtD
Diflunisal—Nausea—Hydroxyurea—brain cancer	0.0011	0.00286	CcSEcCtD
Diflunisal—Asthenia—Carmustine—brain cancer	0.00107	0.00279	CcSEcCtD
Diflunisal—Hypersensitivity—Temozolomide—brain cancer	0.00106	0.00277	CcSEcCtD
Diflunisal—Paraesthesia—Etoposide—brain cancer	0.00104	0.0027	CcSEcCtD
Diflunisal—Asthenia—Temozolomide—brain cancer	0.00103	0.0027	CcSEcCtD
Diflunisal—Dyspnoea—Etoposide—brain cancer	0.00103	0.00268	CcSEcCtD
Diflunisal—Somnolence—Etoposide—brain cancer	0.00103	0.00268	CcSEcCtD
Diflunisal—Diarrhoea—Carmustine—brain cancer	0.00102	0.00266	CcSEcCtD
Diflunisal—Pruritus—Temozolomide—brain cancer	0.00102	0.00266	CcSEcCtD
Diflunisal—Decreased appetite—Etoposide—brain cancer	0.001	0.00262	CcSEcCtD
Diflunisal—Fatigue—Etoposide—brain cancer	0.000994	0.00259	CcSEcCtD
Diflunisal—Dizziness—Carmustine—brain cancer	0.000986	0.00257	CcSEcCtD
Diflunisal—Constipation—Etoposide—brain cancer	0.000986	0.00257	CcSEcCtD
Diflunisal—Diarrhoea—Temozolomide—brain cancer	0.000986	0.00257	CcSEcCtD
Diflunisal—Dizziness—Temozolomide—brain cancer	0.000953	0.00249	CcSEcCtD
Diflunisal—Feeling abnormal—Etoposide—brain cancer	0.00095	0.00248	CcSEcCtD
Diflunisal—Vomiting—Carmustine—brain cancer	0.000948	0.00247	CcSEcCtD
Diflunisal—Gastrointestinal pain—Etoposide—brain cancer	0.000943	0.00246	CcSEcCtD
Diflunisal—Rash—Carmustine—brain cancer	0.00094	0.00245	CcSEcCtD
Diflunisal—Dermatitis—Carmustine—brain cancer	0.00094	0.00245	CcSEcCtD
Diflunisal—Headache—Carmustine—brain cancer	0.000934	0.00244	CcSEcCtD
Diflunisal—Vomiting—Temozolomide—brain cancer	0.000916	0.00239	CcSEcCtD
Diflunisal—Urticaria—Etoposide—brain cancer	0.000916	0.00239	CcSEcCtD
Diflunisal—Body temperature increased—Etoposide—brain cancer	0.000912	0.00238	CcSEcCtD
Diflunisal—Rash—Temozolomide—brain cancer	0.000909	0.00237	CcSEcCtD
Diflunisal—Dermatitis—Temozolomide—brain cancer	0.000908	0.00237	CcSEcCtD
Diflunisal—Headache—Temozolomide—brain cancer	0.000903	0.00236	CcSEcCtD
Diflunisal—Nausea—Carmustine—brain cancer	0.000886	0.00231	CcSEcCtD
Diflunisal—PTGS1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000881	0.0279	CbGpPWpGaD
Diflunisal—Nausea—Temozolomide—brain cancer	0.000856	0.00223	CcSEcCtD
Diflunisal—Hypersensitivity—Etoposide—brain cancer	0.00085	0.00222	CcSEcCtD
Diflunisal—Asthenia—Etoposide—brain cancer	0.000827	0.00216	CcSEcCtD
Diflunisal—Pruritus—Etoposide—brain cancer	0.000816	0.00213	CcSEcCtD
Diflunisal—Diarrhoea—Etoposide—brain cancer	0.000789	0.00206	CcSEcCtD
Diflunisal—Dizziness—Etoposide—brain cancer	0.000763	0.00199	CcSEcCtD
Diflunisal—Vomiting—Etoposide—brain cancer	0.000733	0.00191	CcSEcCtD
Diflunisal—Rash—Etoposide—brain cancer	0.000727	0.0019	CcSEcCtD
Diflunisal—Dermatitis—Etoposide—brain cancer	0.000727	0.0019	CcSEcCtD
Diflunisal—Headache—Etoposide—brain cancer	0.000723	0.00189	CcSEcCtD
Diflunisal—PTGS2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000699	0.0221	CbGpPWpGaD
Diflunisal—Nausea—Etoposide—brain cancer	0.000685	0.00179	CcSEcCtD
Diflunisal—PTGS1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000617	0.0195	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—BSG—brain cancer	0.000535	0.0169	CbGpPWpGaD
Diflunisal—PTGS1—Biological oxidations—CYP2C9—brain cancer	0.000328	0.0104	CbGpPWpGaD
Diflunisal—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000276	0.00873	CbGpPWpGaD
Diflunisal—TTR—Disease—DTX2—brain cancer	0.000268	0.00848	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—GFAP—brain cancer	0.000257	0.00814	CbGpPWpGaD
Diflunisal—PTGS2—S1P1 pathway—VEGFA—brain cancer	0.000241	0.00761	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—CDK6—brain cancer	0.000226	0.00714	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—OR4C12—brain cancer	0.000221	0.00698	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—OR14C36—brain cancer	0.000221	0.00698	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—MPL—brain cancer	0.000217	0.00686	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—CYP2C9—brain cancer	0.000213	0.00673	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—SPP1—brain cancer	0.000209	0.00661	CbGpPWpGaD
Diflunisal—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—brain cancer	0.000202	0.00638	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—SOD2—brain cancer	0.000201	0.00636	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—SOD2—brain cancer	0.0002	0.00632	CbGpPWpGaD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—brain cancer	0.000197	0.00623	CbGpPWpGaD
Diflunisal—TTR—Disease—HES5—brain cancer	0.000197	0.00622	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—DTX2—brain cancer	0.000188	0.00593	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—BSG—brain cancer	0.000181	0.00572	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—S100A10—brain cancer	0.000179	0.00565	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—HES1—brain cancer	0.000166	0.00525	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—SOD2—brain cancer	0.000162	0.00514	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—SOD2—brain cancer	0.00016	0.00505	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—IDH1—brain cancer	0.000155	0.00492	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000155	0.0049	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PTCH2—brain cancer	0.000142	0.0045	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000138	0.00438	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—HES5—brain cancer	0.000138	0.00436	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—STRADA—brain cancer	0.000134	0.00423	CbGpPWpGaD
Diflunisal—TTR—Disease—IDH1—brain cancer	0.000132	0.00419	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000131	0.00415	CbGpPWpGaD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—brain cancer	0.000131	0.00413	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—SOD2—brain cancer	0.000129	0.00408	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000126	0.00398	CbGpPWpGaD
Diflunisal—TTR—Disease—HEY1—brain cancer	0.000125	0.00397	CbGpPWpGaD
Diflunisal—TTR—Disease—DLL1—brain cancer	0.000123	0.00389	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—ENO2—brain cancer	0.000123	0.00389	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000119	0.00375	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—RELA—brain cancer	0.000116	0.00367	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—RELA—brain cancer	0.000115	0.00365	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—MPL—brain cancer	0.000112	0.00354	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—ABR—brain cancer	0.000112	0.00353	CbGpPWpGaD
Diflunisal—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—brain cancer	0.000111	0.00353	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000111	0.0035	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000109	0.00345	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—GLI2—brain cancer	0.000108	0.00341	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—S100A10—brain cancer	0.000107	0.00339	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000107	0.00338	CbGpPWpGaD
Diflunisal—TTR—Disease—SHH—brain cancer	0.000105	0.00331	CbGpPWpGaD
Diflunisal—TTR—Disease—ENO2—brain cancer	0.000105	0.00331	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—GLI1—brain cancer	0.000101	0.0032	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.0001	0.00316	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—CDKN2A—brain cancer	9.94e-05	0.00315	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—CDK4—brain cancer	9.91e-05	0.00314	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—TRPC6—brain cancer	9.61e-05	0.00304	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—SUFU—brain cancer	9.6e-05	0.00304	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—RELA—brain cancer	9.39e-05	0.00297	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—S100A10—brain cancer	9.28e-05	0.00294	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—GFAP—brain cancer	9.26e-05	0.00293	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—RELA—brain cancer	9.22e-05	0.00292	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	9.21e-05	0.00291	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	9.09e-05	0.00288	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	8.92e-05	0.00282	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	8.81e-05	0.00279	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—HEY1—brain cancer	8.78e-05	0.00278	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—DLL1—brain cancer	8.61e-05	0.00273	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—IL2—brain cancer	8.46e-05	0.00268	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—CCND1—brain cancer	8.4e-05	0.00266	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—TRPC6—brain cancer	8.25e-05	0.00261	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	8.19e-05	0.00259	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	8.09e-05	0.00256	CbGpPWpGaD
Diflunisal—PTGS2—Disease—DTX2—brain cancer	7.87e-05	0.00249	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	7.8e-05	0.00247	CbGpPWpGaD
Diflunisal—TTR—Disease—VAV1—brain cancer	7.56e-05	0.00239	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—BSG—brain cancer	7.55e-05	0.00239	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—RELA—brain cancer	7.46e-05	0.00236	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—SHH—brain cancer	7.32e-05	0.00232	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	7.31e-05	0.00231	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—VAV1—brain cancer	7.2e-05	0.00228	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TRPC6—brain cancer	7.06e-05	0.00223	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—SMO—brain cancer	6.94e-05	0.0022	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PTCH1—brain cancer	6.94e-05	0.0022	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	6.74e-05	0.00213	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—MYC—brain cancer	6.74e-05	0.00213	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—IL2—brain cancer	6.57e-05	0.00208	CbGpPWpGaD
Diflunisal—TTR—Disease—HES1—brain cancer	6.5e-05	0.00206	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—CCND1—brain cancer	6.4e-05	0.00203	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—APC—brain cancer	6.35e-05	0.00201	CbGpPWpGaD
Diflunisal—TTR—Disease—PDGFRA—brain cancer	6.19e-05	0.00196	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—VEGFA—brain cancer	6.16e-05	0.00195	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.91e-05	0.00187	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	5.87e-05	0.00186	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HES5—brain cancer	5.78e-05	0.00183	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PIK3CG—brain cancer	5.64e-05	0.00178	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYP2C9—brain cancer	5.61e-05	0.00177	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—NOTCH2—brain cancer	5.55e-05	0.00176	CbGpPWpGaD
Diflunisal—TTR—Disease—IRS2—brain cancer	5.43e-05	0.00172	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—TP53—brain cancer	5.43e-05	0.00172	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—VAV1—brain cancer	5.29e-05	0.00167	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—MYC—brain cancer	5.13e-05	0.00162	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—EGFR—brain cancer	5.02e-05	0.00159	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TRPC6—brain cancer	4.95e-05	0.00157	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	4.93e-05	0.00156	CbGpPWpGaD
Diflunisal—TTR—Disease—APC—brain cancer	4.8e-05	0.00152	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—BSG—brain cancer	4.77e-05	0.00151	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	4.57e-05	0.00145	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—HES1—brain cancer	4.55e-05	0.00144	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP2C9—brain cancer	4.45e-05	0.00141	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	4.35e-05	0.00138	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PDGFRA—brain cancer	4.33e-05	0.00137	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	4.31e-05	0.00136	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	4.29e-05	0.00136	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TP53—brain cancer	4.22e-05	0.00133	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—SPP1—brain cancer	4.21e-05	0.00133	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—IDH1—brain cancer	4.1e-05	0.0013	CbGpPWpGaD
Diflunisal—PTGS2—Disease—IDH1—brain cancer	3.89e-05	0.00123	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IRS2—brain cancer	3.8e-05	0.0012	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	3.8e-05	0.0012	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—BSG—brain cancer	3.79e-05	0.0012	CbGpPWpGaD
Diflunisal—TTR—Disease—ERBB2—brain cancer	3.72e-05	0.00118	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—VAV1—brain cancer	3.71e-05	0.00117	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HEY1—brain cancer	3.68e-05	0.00117	CbGpPWpGaD
Diflunisal—PTGS2—Disease—DLL1—brain cancer	3.61e-05	0.00114	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP2C9—brain cancer	3.6e-05	0.00114	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	3.49e-05	0.00111	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	3.42e-05	0.00108	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PIK3CG—brain cancer	3.36e-05	0.00106	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—APC—brain cancer	3.36e-05	0.00106	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.34e-05	0.00106	CbGpPWpGaD
Diflunisal—TTR—Disease—CTNNB1—brain cancer	3.26e-05	0.00103	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—IDH1—brain cancer	3.26e-05	0.00103	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ENO2—brain cancer	3.24e-05	0.00103	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	3.22e-05	0.00102	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ENO2—brain cancer	3.07e-05	0.000972	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SHH—brain cancer	3.07e-05	0.000972	CbGpPWpGaD
Diflunisal—ALB—Metabolism—BSG—brain cancer	3.06e-05	0.000969	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.87e-05	0.000908	CbGpPWpGaD
Diflunisal—TTR—Disease—STAT3—brain cancer	2.84e-05	0.000899	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	2.73e-05	0.000865	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.65e-05	0.000839	CbGpPWpGaD
Diflunisal—TTR—Disease—MYC—brain cancer	2.64e-05	0.000835	CbGpPWpGaD
Diflunisal—ALB—Metabolism—IDH1—brain cancer	2.63e-05	0.000833	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—RELA—brain cancer	2.62e-05	0.000831	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—ERBB2—brain cancer	2.61e-05	0.000825	CbGpPWpGaD
Diflunisal—TTR—Disease—EGFR—brain cancer	2.58e-05	0.000817	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ENO2—brain cancer	2.57e-05	0.000814	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL2—brain cancer	2.36e-05	0.000748	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PIK3CG—brain cancer	2.36e-05	0.000745	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CCND1—brain cancer	2.3e-05	0.000729	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CTNNB1—brain cancer	2.28e-05	0.000722	CbGpPWpGaD
Diflunisal—PTGS2—Disease—VAV1—brain cancer	2.22e-05	0.000702	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.14e-05	0.000678	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ENO2—brain cancer	2.08e-05	0.000659	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—VEGFA—brain cancer	2.01e-05	0.000636	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—STAT3—brain cancer	1.99e-05	0.000629	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HES1—brain cancer	1.91e-05	0.000604	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MYC—brain cancer	1.85e-05	0.000585	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PDGFRA—brain cancer	1.82e-05	0.000575	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—EGFR—brain cancer	1.81e-05	0.000572	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IL2—brain cancer	1.66e-05	0.000524	CbGpPWpGaD
Diflunisal—PTGS2—Disease—IRS2—brain cancer	1.6e-05	0.000505	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TP53—brain cancer	1.52e-05	0.00048	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PIK3CG—brain cancer	1.49e-05	0.00047	CbGpPWpGaD
Diflunisal—PTGS2—Disease—APC—brain cancer	1.41e-05	0.000446	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—VEGFA—brain cancer	1.41e-05	0.000446	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PIK3CG—brain cancer	1.18e-05	0.000373	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ERBB2—brain cancer	1.09e-05	0.000346	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TP53—brain cancer	1.06e-05	0.000337	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CTNNB1—brain cancer	9.58e-06	0.000303	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PIK3CG—brain cancer	9.55e-06	0.000302	CbGpPWpGaD
Diflunisal—PTGS2—Disease—STAT3—brain cancer	8.35e-06	0.000264	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MYC—brain cancer	7.76e-06	0.000245	CbGpPWpGaD
Diflunisal—PTGS2—Disease—EGFR—brain cancer	7.59e-06	0.00024	CbGpPWpGaD
